96 related articles for article (PubMed ID: 26560441)
21. Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified?
Gleisner AL; Assumpcao L; Cameron JL; Wolfgang CL; Choti MA; Herman JM; Schulick RD; Pawlik TM
Cancer; 2007 Dec; 110(11):2484-92. PubMed ID: 17941009
[TBL] [Abstract][Full Text] [Related]
22. The case for adjuvant chemotherapy in pancreatic cancer.
Ghaneh P; Sultana A; Shore S; Stocken D; Neoptolemos J
Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):383-401. PubMed ID: 16549334
[TBL] [Abstract][Full Text] [Related]
23. Incidence, prognosis, and possible treatment strategies of peritoneal carcinomatosis of pancreatic origin: a population-based study.
Thomassen I; Lemmens VE; Nienhuijs SW; Luyer MD; Klaver YL; de Hingh IH
Pancreas; 2013 Jan; 42(1):72-5. PubMed ID: 22850624
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005).
Corsini MM; Miller RC; Haddock MG; Donohue JH; Farnell MB; Nagorney DM; Jatoi A; McWilliams RR; Kim GP; Bhatia S; Iott MJ; Gunderson LL
J Clin Oncol; 2008 Jul; 26(21):3511-6. PubMed ID: 18640932
[TBL] [Abstract][Full Text] [Related]
25. Older age predicts a decline in adjuvant chemotherapy recommendations for patients with breast carcinoma: evidence from a tertiary care cohort of chemotherapy-eligible patients.
DeMichele A; Putt M; Zhang Y; Glick JH; Norman S
Cancer; 2003 May; 97(9):2150-9. PubMed ID: 12712466
[TBL] [Abstract][Full Text] [Related]
26. p53 expression affects the efficacy of adjuvant chemotherapy after resection of invasive ductal carcinoma of the pancreas.
Nio Y; Dong M; Uegaki K; Hirahara N; Minari Y; Sasaki S; Takamura M; Iguchi C; Tamura K
Anticancer Res; 1998; 18(5B):3773-9. PubMed ID: 9854494
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic and periampullary carcinoma.
Kairaluoma MI; Partio E; Ståhlberg M; Laitinen S
Ann Chir Gynaecol; 1984; 73(4):199-205. PubMed ID: 6210014
[TBL] [Abstract][Full Text] [Related]
28. A national study on adherence to a basal cell carcinoma guideline; development of a tool to assess guideline adherence.
Borgonjen RJ; van Everdingen JJ; Bruijnzeel-Koomen CA; van de Kerkhof PC; Spuls PI
Br J Dermatol; 2015 Apr; 172(4):1008-13. PubMed ID: 25123410
[TBL] [Abstract][Full Text] [Related]
29. Prophylactic hepatic irradiation following curative resection of pancreatic cancer.
Hishinuma S; Ogata Y; Tomikawa M; Ozawa I; Inoue K; Katano S; Tsukiyama I
J Hepatobiliary Pancreat Surg; 2005; 12(3):235-42. PubMed ID: 15995813
[TBL] [Abstract][Full Text] [Related]
30. Survival effects of adjuvant chemoradiotherapy after resection for pancreatic carcinoma.
Yang R; Cheung MC; Byrne MM; Jin X; Montero AJ; Jones C; Koniaris LG
Arch Surg; 2010 Jan; 145(1):49-56. PubMed ID: 20083754
[TBL] [Abstract][Full Text] [Related]
31. Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancer.
Morganti AG; Falconi M; van Stiphout RG; Mattiucci GC; Alfieri S; Calvo FA; Dubois JB; Fastner G; Herman JM; Maidment BW; Miller RC; Regine WF; Reni M; Sharma NK; Ippolito E; Valentini V
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):911-7. PubMed ID: 25220717
[TBL] [Abstract][Full Text] [Related]
32. [Preservation of the pylorus in duodenocephalopancreatectomy in pancreatic and periampullary carcinoma].
Mosca F; Giulianotti PC; Balestracci T; Boggi U; Giardino D; Di Candio G; Rossi G; Fornaciari G
Chir Ital; 1994; 46(2):59-67. PubMed ID: 7954986
[TBL] [Abstract][Full Text] [Related]
33. [Diagnosis and treatment of pancreatic carcinoma in the region of Amsterdam Comprehensive Cancer Care Center in 1997].
Tilleman EH; Benraadt J; Bossuyt PM; Obertop H; Gouma DJ
Ned Tijdschr Geneeskd; 2001 Jul; 145(28):1358-62. PubMed ID: 11484435
[TBL] [Abstract][Full Text] [Related]
34. Borderline resectable pancreatic cancer: rationale for multidisciplinary treatment.
Takahashi S; Kinoshita T; Konishi M; Gotohda N; Kato Y; Kinoshita T; Kobayashi T; Mitsunaga S; Nakachi K; Ikeda M
J Hepatobiliary Pancreat Sci; 2011 Jul; 18(4):567-74. PubMed ID: 21331805
[TBL] [Abstract][Full Text] [Related]
35. [Surgical treatment of 475 patients with periampullary carcinoma].
Liu JF; Li A; Liu Q; Zhou JS; Sun JB; Li D
Zhonghua Zhong Liu Za Zhi; 2005 Apr; 27(4):251-3. PubMed ID: 15949432
[TBL] [Abstract][Full Text] [Related]
36. Intraductal papillary mucinous neoplasms of the pancreas with concurrent pancreatic and periampullary neoplasms.
Sahora K; Crippa S; Zamboni G; Ferrone C; Warshaw AL; Lillemoe K; Mino-Kenudson M; Falconi M; Fernandez-del Castillo C
Eur J Surg Oncol; 2016 Feb; 42(2):197-204. PubMed ID: 26687069
[TBL] [Abstract][Full Text] [Related]
37. Enhancing the quality of care for patients with breast cancer: seven years of experience with a Dutch auditing system.
Veerbeek L; van der Geest L; Wouters M; Guicherit O; Does-den Heijer A; Nortier J; Marinelli A; Tollenaar R; Struikmans H
Eur J Surg Oncol; 2011 Aug; 37(8):714-8. PubMed ID: 21458947
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant treatments for gastric cancer: from practice guidelines to clinical practice.
Bouvier AM; Créhange G; Azélie C; Cheynel N; Jouve JL; Bedenne L; Faivre J; Lepage C; Maingon P
Dig Liver Dis; 2014 Jan; 46(1):72-5. PubMed ID: 23978456
[TBL] [Abstract][Full Text] [Related]
39. An audit of outcomes of a series of periampullary carcinomas.
Berberat PO; Künzli BM; Gulbinas A; Ramanauskas T; Kleeff J; Müller MW; Wagner M; Friess H; Büchler MW
Eur J Surg Oncol; 2009 Feb; 35(2):187-91. PubMed ID: 18343082
[TBL] [Abstract][Full Text] [Related]
40. Impact of lymph node ratio on survival in patients with pancreatic and periampullary cancer.
Tol JA; Brosens LA; van Dieren S; van Gulik TM; Busch OR; Besselink MG; Gouma DJ
Br J Surg; 2015 Feb; 102(3):237-45. PubMed ID: 25529117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
